Tolerogenic IDO+ dendritic cells are induced by PD-1-expressing mast cells

Cited by papers we hold 4

• Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives · 2022
  No notice
• IDO Expression in Cancer: Different Compartment, Different Functionality? · 2020
  No notice
• Targeting the IDO1 pathway in cancer: from bench to bedside · 2018
  No notice
• Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.